198 related articles for article (PubMed ID: 9386214)
21. Efficacy and tolerability of local estrogen therapy for urogenital atrophy.
Archer DF
Menopause; 2010; 17(1):194-203. PubMed ID: 19602990
[TBL] [Abstract][Full Text] [Related]
22. Estrogens and the urogenital tract. Studies on steroid hormone receptors and a clinical study on a new estradiol-releasing vaginal ring.
Smith P
Acta Obstet Gynecol Scand Suppl; 1993; 157():1-26. PubMed ID: 8393609
[TBL] [Abstract][Full Text] [Related]
23. Local oestrogen for vaginal atrophy in postmenopausal women.
Suckling J; Lethaby A; Kennedy R
Cochrane Database Syst Rev; 2003; (4):CD001500. PubMed ID: 14583935
[TBL] [Abstract][Full Text] [Related]
24. Progress and prospects in treating postmenopausal vaginal atrophy.
Winneker RC; Harris HA
Clin Pharmacol Ther; 2011 Jan; 89(1):129-32. PubMed ID: 20944561
[TBL] [Abstract][Full Text] [Related]
25. [Topical hormonal treatment and urogenital atrophy].
Sitruk-Ware R; Thomas JL
Praxis (Bern 1994); 1997 Aug; 86(33):1245-8. PubMed ID: 9381009
[TBL] [Abstract][Full Text] [Related]
26. Urogenital atrophy: prevention and treatment.
Willhite LA; O'Connell MB
Pharmacotherapy; 2001 Apr; 21(4):464-80. PubMed ID: 11310520
[TBL] [Abstract][Full Text] [Related]
27. Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview.
Al-Baghdadi O; Ewies AA
Climacteric; 2009 Apr; 12(2):91-105. PubMed ID: 19117185
[TBL] [Abstract][Full Text] [Related]
28. Women's preferences toward attributes of local estrogen therapy for the treatment of vaginal atrophy.
Mattsson LÅ; Ericsson Å; Bøgelund M; Maamari R
Maturitas; 2013 Mar; 74(3):259-63. PubMed ID: 23312488
[TBL] [Abstract][Full Text] [Related]
29. The role of vaginal estrogen in the treatment of urogenital dysfunction in postmenopausal women.
Bernier F; Jenkins P
Urol Nurs; 1997 Sep; 17(3):92-5. PubMed ID: 9349043
[TBL] [Abstract][Full Text] [Related]
30. Safety of vaginal estrogens: a systematic review.
Crandall CJ; Diamant A; Santoro N
Menopause; 2020 Mar; 27(3):339-360. PubMed ID: 31913230
[TBL] [Abstract][Full Text] [Related]
31. The effects of hormones on urinary incontinence in postmenopausal women.
Quinn SD; Domoney C
Climacteric; 2009 Apr; 12(2):106-13. PubMed ID: 19259853
[TBL] [Abstract][Full Text] [Related]
32. A prospective randomized comparative study of the effects of intranasal and transdermal 17 beta-estradiol on postmenopausal symptoms and vaginal cytology.
Odabaşi AR; Yüksel H; Demircan SS; Kaçar DF; Culhaci N; Ozkara EE
J Postgrad Med; 2007; 53(4):221-7. PubMed ID: 18097108
[TBL] [Abstract][Full Text] [Related]
33. Managing urogenital atrophy.
Palacios S
Maturitas; 2009 Aug; 63(4):315-8. PubMed ID: 19493638
[TBL] [Abstract][Full Text] [Related]
34. Not time to abandon use of local vaginal hormone therapies.
Pinkerton JV; Kaunitz AM; Manson JE
Menopause; 2018 Aug; 25(8):855-858. PubMed ID: 29894370
[No Abstract] [Full Text] [Related]
35. The effect of estradiol vaginal tablet and conjugated estrogen cream on urogenital symptoms in postmenopausal women: a comparative study.
Manonai J; Theppisai U; Suthutvoravut S; Udomsubpayakul U; Chittacharoen A
J Obstet Gynaecol Res; 2001 Oct; 27(5):255-60. PubMed ID: 11776507
[TBL] [Abstract][Full Text] [Related]
36. The role of estrogens in female lower urinary tract dysfunction.
Robinson D; Cardozo LD
Urology; 2003 Oct; 62(4 Suppl 1):45-51. PubMed ID: 14550837
[TBL] [Abstract][Full Text] [Related]
37. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
Palacios S; Castelo-Branco C; Cancelo MJ; Vázquez F
Maturitas; 2005 Feb; 50(2):98-104. PubMed ID: 15653006
[TBL] [Abstract][Full Text] [Related]
38. The detection and management of vaginal atrophy.
Johnston SL; Farrell SA; Bouchard C; Farrell SA; Beckerson LA; Comeau M; Johnston SL; Lefebvre G; Papaioannou A;
J Obstet Gynaecol Can; 2004 May; 26(5):503-15. PubMed ID: 15151738
[TBL] [Abstract][Full Text] [Related]
39. Estrogen for vulvovaginal symptoms: how low can you go?
Brzezinski A; Benshushan A
Menopause; 2009; 16(5):848-50. PubMed ID: 19564805
[No Abstract] [Full Text] [Related]
40. Geriatric aspects on estrogen effects and sexuality.
Sourander LB
Gerontology; 1994; 40 Suppl 3():14-7. PubMed ID: 7851799
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
